Michelle Roseman1, Nazanin Saadat2, Kira E Riehm2, Lorie A Kloda3, Jill Boruff4, Abel Ickowicz5, Franziska Baltzer6,7, Laurence Y Katz8, Scott B Patten9, Cécile Rousseau10, Brett D Thombs2,10,11,12,13,14. 1. 1 Department of Family and Community Medicine, University of Toronto, Ontario. 2. 2 Lady Davis Institute, Jewish General Hospital, Montréal, Québec. 3. 3 Library, Concordia University, Montréal, Québec. 4. 4 Schulich Library of Science and Engineering, McGill University, Montréal, Québec. 5. 5 Department of Psychiatry, Hospital for Sick Children, University of Toronto, Toronto, Ontario. 6. 6 Montréal Children's Hospital, Montréal, Québec. 7. 7 Department of Pediatrics, McGill University, Montréal, Québec. 8. 8 Department of Psychiatry, University of Manitoba, Winnipeg. 9. 9 Departments of Psychiatry and Community Health Sciences, University of Calgary, Calgary, Alberta. 10. 10 Department of Psychiatry, McGill University, Montréal, Québec. 11. 11 Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montréal, Québec. 12. 12 Department of Medicine, McGill University, Montréal, Québec. 13. 13 Department of Educational and Counselling Psychology, McGill University, Montréal, Québec. 14. 14 Department of Psychology, McGill University, Montréal, Québec.
Abstract
OBJECTIVE: Depression screening among children and adolescents is controversial. In 2009, the United States Preventive Services Task Force first recommended routine depression screening for adolescents, and this recommendation was reiterated in 2016. However, no randomized controlled trials (RCTs) of screening were identified in the original 2009 systematic review or in an updated review through February 2015. The objective of this systematic review was to provide a current evaluation to determine whether there is evidence from RCTs that depression screening in childhood and adolescence improves depression outcomes. METHOD: Data sources included the MEDLINE, MEDLINE In-Process, EMBASE, PsycINFO, Cochrane CENTRAL and LILACS databases searched February 2, 2017. Eligible studies had to be RCTs that compared depression outcomes between children or adolescents aged 6 to 18 years who underwent depression screening and those who did not. RESULTS: Of 552 unique title/abstracts, none received full-text review. No RCTs that investigated the effects of screening on depression outcomes in children or adolescents were identified. CONCLUSIONS: There is no direct RCT evidence that supports depression screening among children and adolescents. Groups that consider recommending screening should carefully consider potential harms, as well as the use of scarce health resources, that would occur with the implementation of screening programs.
OBJECTIVE:Depression screening among children and adolescents is controversial. In 2009, the United States Preventive Services Task Force first recommended routine depression screening for adolescents, and this recommendation was reiterated in 2016. However, no randomized controlled trials (RCTs) of screening were identified in the original 2009 systematic review or in an updated review through February 2015. The objective of this systematic review was to provide a current evaluation to determine whether there is evidence from RCTs that depression screening in childhood and adolescence improves depression outcomes. METHOD: Data sources included the MEDLINE, MEDLINE In-Process, EMBASE, PsycINFO, Cochrane CENTRAL and LILACS databases searched February 2, 2017. Eligible studies had to be RCTs that compared depression outcomes between children or adolescents aged 6 to 18 years who underwent depression screening and those who did not. RESULTS: Of 552 unique title/abstracts, none received full-text review. No RCTs that investigated the effects of screening on depression outcomes in children or adolescents were identified. CONCLUSIONS: There is no direct RCT evidence that supports depression screening among children and adolescents. Groups that consider recommending screening should carefully consider potential harms, as well as the use of scarce health resources, that would occur with the implementation of screening programs.
Entities:
Keywords:
child and adolescent psychiatry; depressive disorders; screening
Authors: Michel Joffres; Alejandra Jaramillo; James Dickinson; Gabriela Lewin; Kevin Pottie; Elizabeth Shaw; Sarah Connor Gorber; Marcello Tonelli Journal: CMAJ Date: 2013-05-13 Impact factor: 8.262
Authors: Valerie Forman-Hoffman; Emily McClure; Joni McKeeman; Charles T Wood; Jennifer Cook Middleton; Asheley C Skinner; Eliana M Perrin; Meera Viswanathan Journal: Ann Intern Med Date: 2016-02-09 Impact factor: 25.391
Authors: Brett D Thombs; Michelle Roseman; James C Coyne; Peter de Jonge; Vanessa C Delisle; Erin Arthurs; Brooke Levis; Roy C Ziegelstein Journal: PLoS One Date: 2013-01-07 Impact factor: 3.240
Authors: Andrew Beck; John C LeBlanc; Kate Morissette; Candyce Hamel; Becky Skidmore; Heather Colquhoun; Eddy Lang; Ainsley Moore; John J Riva; Brett D Thombs; Scott Patten; Heather Bragg; Ian Colman; Gary S Goldfield; Stuart Gordon Nicholls; Kathleen Pajer; Beth K Potter; Robert Meeder; Priya Vasa; Brian Hutton; Beverley J Shea; Eva Graham; Julian Little; David Moher; Adrienne Stevens Journal: Syst Rev Date: 2021-01-12